3.5 Acute Lymphoblastic Leukemia (B-ALL & T-ALL) Subtyping

Acute Lymphoblastic Leukemia (B-ALL & T-ALL) Subtyping

Acute Lymphoblastic Leukemia (ALL) is a neoplasm of immature lymphoid precursors (lymphoblasts) and is the most common pediatric cancer, though it also affects adults. Flow cytometry is absolutely essential for diagnosing ALL and determining its lineage: B-lymphoblastic leukemia (B-ALL) or T-lymphoblastic leukemia (T-ALL). Accurate subtyping dictates the therapeutic protocol.

Defining the Lymphoblast

Similar to myeloblasts, lymphoblasts fall into the CD45 dim / SSC low "blast gate". However, lymphoblasts generally have even lower side scatter than myeloblasts because their cytoplasm is essentially agranular. They typically express markers of cellular immaturity, including CD34 and TdT (Terminal deoxynucleotidyl transferase, a nuclear enzyme highly specific for early lymphoid precursors).

B-Cell Acute Lymphoblastic Leukemia (B-ALL)

B-ALL is the most common type of ALL. The blasts are arrested at an early stage of B-cell development in the bone marrow. Assigning B-lineage relies on the strong expression of B-cell specific antigens.

Key markers for B-ALL:

• CD19: A pan-B cell marker, usually uniformly and strongly positive on B-lymphoblasts.
• Cytoplasmic CD79a (cCD79a): A highly specific B-cell marker, often positive even in very early precursors.
• Cytoplasmic CD22 (cCD22): Another specific B-cell marker expressed early in development.
• CD10 (CALLA): The Common Acute Lymphoblastic Leukemia Antigen. It is positive in the majority of B-ALL cases (historically termed "common ALL").
• TdT and CD34: Markers of immaturity, typically positive.
• Surface Immunoglobulin (sIg): Typically negative. If the blasts express surface kappa or lambda light chains, it indicates a mature B-cell neoplasm (like Burkitt Lymphoma or the leukemic phase of a mature B-cell lymphoma), not B-ALL.
• CD20: Often negative or only dimly/heterogeneously positive, as it is a later maturation marker. However, CD20 expression levels are important as they may dictate the use of anti-CD20 targeted therapies (e.g., rituximab).

B-ALL Maturation Stages: Flow cytometry can subdivide B-ALL based on normal developmental stages:

1. Pro-B ALL (Early Pre-B): CD19+, TdT+, CD34+, but CD10 negative. Often associated with specific genetic abnormalities like KMT2A (MLL) rearrangements.
2. Common B-ALL: CD19+, TdT+, CD34+, and CD10 strongly positive.
3. Pre-B ALL: Similar to common B-ALL but characterized by the presence of cytoplasmic IgM (cIgM) (mu heavy chains), while still lacking surface light chains.

T-Cell Acute Lymphoblastic Leukemia (T-ALL)

T-ALL arises from immature T-cell precursors, often presenting with a high white blood cell count and a mediastinal mass (thymic involvement). Assigning T-lineage requires specific markers, as some pan-T markers can be aberrantly expressed in AML.

Key markers for T-ALL:

• Cytoplasmic CD3 (cCD3): This is the most specific and defining marker for T-cell lineage. Surface CD3 (sCD3) is often negative or very dim on T-lymphoblasts, making intracellular staining for cCD3 absolutely critical for the diagnosis.
• CD7: A very sensitive pan-T marker, usually brightly positive. However, it is not perfectly specific, as it can be aberrantly expressed on myeloblasts.
• CD5 and CD2: Other pan-T markers frequently positive in T-ALL.
• CD1a: A marker of cortical thymocytes. Its presence indicates a specific stage of T-cell maturation (cortical T-ALL).
• CD4 and CD8: T-lymphoblasts often exhibit anomalous expression of these mature T-cell subsets. They can be double-negative (CD4-/CD8-), double-positive (CD4+/CD8+), or single positive.
• TdT and CD34: Markers of immaturity. TdT is almost always positive, while CD34 is variable.

Early T-cell Precursor (ETP) ALL: ETP-ALL is a high-risk subtype of T-ALL with a distinct phenotype. It is defined by the absence or weak expression of CD5, the absence of CD1a and CD8, and the aberrant expression of myeloid or stem-cell markers (such as CD13, CD33, CD11b, CD65, or HLA-DR).

Aberrancies in ALL

Similar to AML, lymphoblasts often exhibit Leukemia-Associated Immunophenotypes (LAIPs). For instance, B-ALL blasts frequently overexpress CD10, aberrantly express myeloid markers (like CD13 or CD33), or show asynchronous maturation patterns. Recognizing these unique cellular fingerprints is critical for subsequent minimal residual disease (MRD) monitoring, which is particularly vital in pediatric B-ALL to guide risk-adapted therapy.

General Quality Control and Instrument Optimization in Flow Cytometry

Quality control (QC) is fundamentally critical to the daily operation of a clinical flow cytometry laboratory. Ensuring that the instrument is performing optimally before analyzing patient samples guarantees that the data generated is accurate, reproducible, and clinically actionable. The basic components of flow cytometry QC include fluidics checks, optics alignment, and electronics calibration, all of which must be monitored continuously to maintain data integrity. Quality control (QC) is fundamentally critical to the daily operation of a clinical flow cytometry laboratory. Ensuring that the instrument is performing optimally before analyzing patient samples guarantees that the data generated is accurate, reproducible, and clinically actionable. The basic components of flow cytometry QC include fluidics checks, optics alignment, and electronics calibration, all of which must be monitored continuously to maintain data integrity. Quality control (QC) is fundamentally critical to the daily operation of a clinical flow cytometry laboratory. Ensuring that the instrument is performing optimally before analyzing patient samples guarantees that the data generated is accurate, reproducible, and clinically actionable. The basic components of flow cytometry QC include fluidics checks, optics alignment, and electronics calibration, all of which must be monitored continuously to maintain data integrity. Quality control (QC) is fundamentally critical to the daily operation of a clinical flow cytometry laboratory. Ensuring that the instrument is performing optimally before analyzing patient samples guarantees that the data generated is accurate, reproducible, and clinically actionable. The basic components of flow cytometry QC include fluidics checks, optics alignment, and electronics calibration, all of which must be monitored continuously to maintain data integrity. Quality control (QC) is fundamentally critical to the daily operation of a clinical flow cytometry laboratory. Ensuring that the instrument is performing optimally before analyzing patient samples guarantees that the data generated is accurate, reproducible, and clinically actionable. The basic components of flow cytometry QC include fluidics checks, optics alignment, and electronics calibration, all of which must be monitored continuously to maintain data integrity. Quality control (QC) is fundamentally critical to the daily operation of a clinical flow cytometry laboratory. Ensuring that the instrument is performing optimally before analyzing patient samples guarantees that the data generated is accurate, reproducible, and clinically actionable. The basic components of flow cytometry QC include fluidics checks, optics alignment, and electronics calibration, all of which must be monitored continuously to maintain data integrity. Quality control (QC) is fundamentally critical to the daily operation of a clinical flow cytometry laboratory. Ensuring that the instrument is performing optimally before analyzing patient samples guarantees that the data generated is accurate, reproducible, and clinically actionable. The basic components of flow cytometry QC include fluidics checks, optics alignment, and electronics calibration, all of which must be monitored continuously to maintain data integrity. Quality control (QC) is fundamentally critical to the daily operation of a clinical flow cytometry laboratory. Ensuring that the instrument is performing optimally before analyzing patient samples guarantees that the data generated is accurate, reproducible, and clinically actionable. The basic components of flow cytometry QC include fluidics checks, optics alignment, and electronics calibration, all of which must be monitored continuously to maintain data integrity. Quality control (QC) is fundamentally critical to the daily operation of a clinical flow cytometry laboratory. Ensuring that the instrument is performing optimally before analyzing patient samples guarantees that the data generated is accurate, reproducible, and clinically actionable. The basic components of flow cytometry QC include fluidics checks, optics alignment, and electronics calibration, all of which must be monitored continuously to maintain data integrity. Quality control (QC) is fundamentally critical to the daily operation of a clinical flow cytometry laboratory. Ensuring that the instrument is performing optimally before analyzing patient samples guarantees that the data generated is accurate, reproducible, and clinically actionable. The basic components of flow cytometry QC include fluidics checks, optics alignment, and electronics calibration, all of which must be monitored continuously to maintain data integrity. Daily QC protocols typically begin with the evaluation of standard calibration beads, which allow the operator to assess laser alignment, verify the stability of optical paths, and measure the consistency of fluidic flow rates. These beads are manufactured to exhibit uniform and precise fluorescent intensities across all measured channels. By analyzing these standard particles, the laboratory can record target values, monitor coefficients of variation (CVs), and track long-term performance using Levey-Jennings charts. Tracking CVs is crucial because any unexplained increase in the variability of a bead's signal usually indicates an underlying problem with the fluidic stream or partial obstruction in the flow cell, which can drastically reduce resolution. Daily QC protocols typically begin with the evaluation of standard calibration beads, which allow the operator to assess laser alignment, verify the stability of optical paths, and measure the consistency of fluidic flow rates. These beads are manufactured to exhibit uniform and precise fluorescent intensities across all measured channels. By analyzing these standard particles, the laboratory can record target values, monitor coefficients of variation (CVs), and track long-term performance using Levey-Jennings charts. Tracking CVs is crucial because any unexplained increase in the variability of a bead's signal usually indicates an underlying problem with the fluidic stream or partial obstruction in the flow cell, which can drastically reduce resolution. Daily QC protocols typically begin with the evaluation of standard calibration beads, which allow the operator to assess laser alignment, verify the stability of optical paths, and measure the consistency of fluidic flow rates. These beads are manufactured to exhibit uniform and precise fluorescent intensities across all measured channels. By analyzing these standard particles, the laboratory can record target values, monitor coefficients of variation (CVs), and track long-term performance using Levey-Jennings charts. Tracking CVs is crucial because any unexplained increase in the variability of a bead's signal usually indicates an underlying problem with the fluidic stream or partial obstruction in the flow cell, which can drastically reduce resolution. Daily QC protocols typically begin with the evaluation of standard calibration beads, which allow the operator to assess laser alignment, verify the stability of optical paths, and measure the consistency of fluidic flow rates. These beads are manufactured to exhibit uniform and precise fluorescent intensities across all measured channels. By analyzing these standard particles, the laboratory can record target values, monitor coefficients of variation (CVs), and track long-term performance using Levey-Jennings charts. Tracking CVs is crucial because any unexplained increase in the variability of a bead's signal usually indicates an underlying problem with the fluidic stream or partial obstruction in the flow cell, which can drastically reduce resolution. Daily QC protocols typically begin with the evaluation of standard calibration beads, which allow the operator to assess laser alignment, verify the stability of optical paths, and measure the consistency of fluidic flow rates. These beads are manufactured to exhibit uniform and precise fluorescent intensities across all measured channels. By analyzing these standard particles, the laboratory can record target values, monitor coefficients of variation (CVs), and track long-term performance using Levey-Jennings charts. Tracking CVs is crucial because any unexplained increase in the variability of a bead's signal usually indicates an underlying problem with the fluidic stream or partial obstruction in the flow cell, which can drastically reduce resolution. Compensation matrices must also be reviewed and updated regularly, particularly in complex multi-color panels used in clinical diagnostic immunophenotyping. Compensation matrices must also be reviewed and updated regularly, particularly in complex multi-color panels used in clinical diagnostic immunophenotyping. Compensation matrices must also be reviewed and updated regularly, particularly in complex multi-color panels used in clinical diagnostic immunophenotyping. Compensation matrices must also be reviewed and updated regularly, particularly in complex multi-color panels used in clinical diagnostic immunophenotyping. Compensation matrices must also be reviewed and updated regularly, particularly in complex multi-color panels used in clinical diagnostic immunophenotyping.